As shown in Fig. 4a, overexpression of cyclin G2 inhibited the β-catenin/TCF-mediated transcription of SGC-7901 and MGC-803 cells, suggesting that cyclin G2 acted as a negative regulator of the Wnt/β-catenin signaling in gastric cancer cells. The gene discussed is CCNG2; the disease is gastric cancer.